We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

55 hedge funds and large institutions have $200M invested in Vicarious Surgical in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 4

67% more funds holding

Funds holding: 3355 (+22)

33% more capital invested

Capital invested by funds: $151M → $200M (+$49.7M)

0.36% more ownership

Funds ownership: 1.56%1.92% (+0.36%)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

Holders
55
Holders Change
+22
Holders Change %
+66.67%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
11
Reduced
11
Closed
4
Calls
$4.42M
Puts
Net Calls
+$4.42M
Net Calls Change
+$4.42M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
26
Moore Capital Management
New York
$2.54M
BCM
27
Beryl Capital Management
California
$2.54M +$2.45M +8,333 New
BFM
28
Boothbay Fund Management
New York
$2.54M +$2.45M +8,333 New
TCM
29
Tenor Capital Management
New York
$2.03M -$2.94M -10,000 -60%
CCA
30
Castle Creek Arbitrage
Colorado
$2.03M +$1.96M +6,667 New
WCMNY
31
Westchester Capital Management (New York)
New York
$2.03M +$1.96M +6,667 New
CCM
32
Context Capital Management
California
$1.59M +$1.53M +5,222 New
AA
33
AQR Arbitrage
Connecticut
$1.52M -$1.47M -5,000 -50%
KIM
34
Karpus Investment Management
New York
$1.16M
Walleye Trading
35
Walleye Trading
New York
$1.11M -$216K -736 -17%
CIM
36
Cowen Investment Management
New York
$1.02M +$979K +3,333 New
OCAM
37
Owl Creek Asset Management
New York
$914K -$4.99M -17,000 -85%
PCR
38
Potrero Capital Research
California
$784K +$755K +2,571 New
BSCM
39
Berry Street Capital Management
United Kingdom
$762K +$734K +2,500 New
EAM
40
Exos Asset Management
New York
$747K +$720K +2,450 New
OFG
41
OTA Financial Group
New York
$722K -$411K -1,398 -37%
JG
42
Jefferies Group
New York
$520K -$478K -1,628 -49%
UBS Group
43
UBS Group
Switzerland
$491K +$469K +1,596 +12,277%
EIP
44
Easterly Investment Partners
Massachusetts
$406K
CC
45
Centiva Capital
New York
$406K +$196K +666 +100%
SSA
46
Schonfeld Strategic Advisors
New York
$362K +$84.3K +287 +32%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$354K +$341K +1,160 New
Arrowstreet Capital
48
Arrowstreet Capital
Massachusetts
$353K +$340K +1,157 New
TCM
49
Tuttle Capital Management
Connecticut
$349K +$337K +1,146 New
SCM
50
Saba Capital Management
New York
$256K +$246K +839 New

RBOT Hedge Fund Activity: Q4 2020 in Review

55 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2020, worth a combined $200M — up 33% from $151M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RBOT positions and 4 closed out — a net gain of 22 holders — while 11 added to existing stakes and 11 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $9.59M. The largest seller was Athanor Capital, exiting entirely with an estimated $16.1M sold.

  • 55 institutional investors held Vicarious Surgical (RBOT) as of Q4 2020, up from 33 in Q3 2020.
  • Funds reported $200M of Vicarious Surgical stock for Q4 2020, up 33% quarter-over-quarter.
  • 26 funds opened new Vicarious Surgical positions in Q4 2020 and 4 closed out, a net change of +22 holders.
  • The largest Vicarious Surgical buyer in Q4 2020 was Marshall Wace, an estimated $9.59M added.
  • The largest Vicarious Surgical seller in Q4 2020 was Athanor Capital, an estimated $16.1M sold.

Based on aggregated 13F filings for Q4 2020.